ID   14D10
AC   CVCL_C7ID
DR   Wikidata; Q123030222
RX   PubMed=9683260;
RX   PubMed=24502396;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized YS110 (YSCMA) therapeutic antibody which is in clinical trials for the treatment of malignant mesothelioma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=24502396; DOI=10.1186/1746-1596-9-30; PMCID=PMC3944398;
RA   Hatano, Ryo
RA   Yamada, Taketo
RA   Matsuoka, Shuji
RA   Iwata, Satoshi
RA   Yamazaki, Hiroto
RA   Komiya, Eriko
RA   Okamoto, Toshihiro
RA   Dang, Nam Hoang
RA   Ohnuma, Kei
RA   Morimoto, Chikao
RT   "Establishment of monoclonal anti-human CD26 antibodies suitable for
RT   immunostaining of formalin-fixed tissue.";
RL   Diagn. Pathol. 9:30.1-30.13(2014).
//
RX   PubMed=9683260; DOI=10.1016/S0161-5890(98)00015-7;
RA   Dong, Rui-Ping
RA   Tachibana, Kouichi
RA   Hegen, Martin
RA   Scharpe, Simon
RA   Cho, Donny
RA   Schlossman, Stuart Franklin
RA   Morimoto, Chikao
RT   "Correlation of the epitopes defined by anti-CD26 mAbs and CD26
RT   function.";
RL   Mol. Immunol. 35:13-21(1998).
//